Market Pulse: Genentech suspends phase II trial of cancer drug Avastin
25th Sep 2005, 00:02 GMT
Genentech that it's suspended a phase II clinical trial of Avastin, a cancer treatment, due to a higher rate of GI perforations.
Latest news from Obstetrics/ Gynecology News from StratCenter.com:
- Acusphere Reports Q3 2006 Financial Results and Accomplishments
- CuraGen and TopoTarget Announce Initiation of NCI-Sponsored Phase II Trial of PXD101 for Ovarian Cancer
- Twin Cities Takes Action to Save Babies
- Substantial Regression of Atherosclerosis May Help Improve Diseased Arteries
- EDAP TMS SA to Participate in Int'l Urology Conferences
- Misonix Showcases SonicOne Ultrasonic Wound Debrider with Medline at MEDICA 2006 in Germany
- 8 Studies Evaluating Cytyc's Novasure System Presented at AAGL Meeting